Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Prefabricated CAD/CAM PEEK Crowns For Primary Molars Restoration

28 maggio 2026 aggiornato da: Arab International University

Evaluation of Minimally Prepared CAD/CAM Polyetheretherketone (PEEK) Crowns Efficacy in Restoring Primary Molars

This Split-mouth randomized clinical trial aims to evaluate CAD/CAM prefabricated Polyether ether ketone crowns for primary molars restoration after pulpotomy compared to Stainless steel crowns Over follow-up periods of 3, 6, and 12 months, the sample included 60 children aged 5-9 years who had bilateral mandibular second primary molars.

Each child received a pulpotomy treatment followed by the placement of a stainless steel crown on one side and a PEEK crown on the contralateral side, distributed randomly.

Clinical parameters were subsequently evaluated during the three follow-up periods, including the gingival index, plaque index, bleeding on probing index, restoration retention and integrity, marginal adaptation, color stability, and both parental and child satisfaction.

Panoramica dello studio

Descrizione dettagliata

Interest in the esthetic aspect of pediatric dental treatment has increased among both children and parents, as children's self-perception is strongly influenced by the appearance of their teeth from an early age. Most esthetic restorative options require extensive tooth preparation compared with stainless steel crowns (SSCs). However, only limited studies have investigated conservative esthetic alternatives for primary molars.

This randomized controlled clinical trial aimed to evaluate the clinical effectiveness of CAD-CAM prefabricated esthetic PEEK crowns compared with stainless steel crowns (SSCs) in restoring primary mandibular second molars after pulpotomy. Clinical performance was assessed according to restoration retention and integrity, gingival health, plaque accumulation, bleeding on probing, marginal adaptation, color stability, and child/parent satisfaction over follow-up periods of 3, 6, and 12 months.

The sample was randomly allocated using the website: randomization.com

A total crowns were randomly distributed into four groups (n=20 per group):

(A): Prefabricated CAD/CAM PEEK crowns with 0.2 mm thickness (B): Prefabricated CAD/CAM PEEK crowns with 0.4 mm thickness (C): CAD/CAM fabricated PEEK crowns prepared according to NuSmile recommendations (D): Stainless steel crowns (SSC). The study included healthy, cooperative children aged 5-9 years requiring pulpotomy treatment for mandibular second primary.

Clinical Procedure

Clinical and radiographic examinations are performed to confirm the indication for pulpotomy treatment, followed by completion of the study form. Local anesthesia and rubber dam isolation are carried out, and pulpotomy is performed according to the conventional technique described by Dean (2016). The tooth is then restored with glass ionomer cement.

After cement setting, conservative tooth preparation is performed using diamond burs with 1-2 mm occlusal reduction. For Groups I, II, and IV, proximal reduction is completed with minimal preparation. In Group III, tooth preparation follows NuSmile recommendations, including occlusal reduction, proximal opening, crown reduction, and a 1 mm subgingival finish line.

For Groups I, II, and IV, the appropriate crown size is selected, checked for marginal adaptation and proximal contacts, then cemented using Fuji I glass ionomer cement. Excess cement is removed using a dental explorer and dental floss.

For the CAD/CAM fabricated PEEK group, a silicone impression is taken and scanned digitally. Crowns are designed using Exocad software and fabricated with CAD-CAM technology. After polishing and internal surface conditioning with aluminum oxide particles, the crown is tried in, cemented with Fuji I glass ionomer cement, and excess cement is removed.

Clinical parameters are evaluated immediately after crown cementation for directly measurable baseline variables and during the three follow-up periods (after 3, 6, 12 months), including the gingival index, plaque index, bleeding on probing index, restoration retention and integrity, marginal adaptation, color stability, and both parental and child satisfaction.

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Damascus, Siria
        • School of Dental Medicine

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  1. Healthy children aged 5-9 years.
  2. Children requiring pulpotomy of mandibular second primary molars.
  3. Cooperative children rated as positive or definitely positive on the Frankl behavior scale.
  4. No acute or chronic abscess at the anesthesia site.

Exclusion Criteria:

  1. Root resorption exceeding the apical third.
  2. Non-restorable teeth.
  3. Presence of swelling, fistula, or acute or chronic pulpitis.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Prefabricated PEEK crowns of 0.2 mm thickness
Minimally prepared teeth restored with prefabricated PEEK crowns of 0.2 mm wall thickness.
The pulpotomized molar assigned to experimental group will be received A Polyether ether ketone prefabricated crown with 0.2mm thickness on one side of mandibular arch, and the other side will be received a Stainless steel crown as control group.
Sperimentale: Prefabricated PEEK crowns of 0.4 mm wall thickness
Minimally prepared teeth restored with prefabricated PEEK crowns of 0.4 mm wall thickness.
The pulpotomized molar assigned to experimental group will be received A Polyether ether ketone prefabricated crown with 0.4mm thickness on one side of mandibular arch, and the other side will be received a Stainless steel crown as control group.
Sperimentale: CAD/CAM-fabricated PEEK crowns
Teeth receiving comprehensive preparation and restored with CAD/CAM-fabricated PEEK crowns following the NuSmile preparation protocol.
The pulpotomized molar assigned to experimental group will be received A CAD/CAM fabricated Polyether ether ketone crown on one side of mandibular arch, and the other side will be received a Stainless steel crown as control group.
Comparatore attivo: Stainless steel crowns
Minimally prepared teeth restored with prefabricated stainless steel crowns, as the positive control group.
The pulpotomized molar assigned to control group will be received a Stainless steel crown as control group on one side of mandibular arch, and the other side will be received one of the arm 1, 2, or 3

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Gingival Index
Lasso di tempo: Baseline, 3 months, 6 months, and 12 months postoperatively

0 = No gingival inflammation.

  1. = Mild inflammation with slight changes in color and texture affecting part of the marginal gingiva or papilla.
  2. = Mild inflammation with changes in color and texture involving the entire marginal gingiva or papilla.
  3. = Moderate gingival inflammation with obvious redness, surface glazing, edema, and/or enlargement of the marginal gingiva or papilla.
  4. = Severe gingival inflammation with marked redness, edema and/or enlargement of the marginal gingiva or papilla, spontaneous bleeding, and ulceration.
Baseline, 3 months, 6 months, and 12 months postoperatively
Plaque Index
Lasso di tempo: Baseline, 3 months, 6 months, and 12 months postoperatively

0 = No plaque accumulation around the gingival margin.

  1. = Slight plaque accumulation detected only by passing a probe.
  2. = Moderate plaque accumulation visible to the naked eye.
  3. = Heavy plaque accumulation on the crown surface, gingiva, and interdental areas.
Baseline, 3 months, 6 months, and 12 months postoperatively
Bleeding on Probing
Lasso di tempo: Baseline, 3 months, 6 months, and 12 months postoperatively

Bleeding on probing is assessed using a Williams periodontal probe inserted into the gingival sulcus around each crowned tooth. Four sites (mesial, distal, buccal, and lingual) are examined, and bleeding is evaluated 10 seconds after probing as follows:

(-) No bleeding. (+) Bleeding present.

Baseline, 3 months, 6 months, and 12 months postoperatively
Wong-Baker Faces Scale
Lasso di tempo: Baseline, 3 months, 6 months, 12 months postoperatively

A Wong-Baker Faces Scale consisting of six expressive faces is used, ranging from "no hurts" to "hurts worst," to facilitate the child's selection of the appropriate face. The scale ranges from 0 to 10.

The child is given a questionnaire displaying the faces immediately after crown placement and is asked to choose the face that best represents their feeling at that moment. The child indicates the selected face by pointing to it, and the response is recorded in the study form.

Baseline, 3 months, 6 months, 12 months postoperatively

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Color Stability
Lasso di tempo: 3 months, 6 months, 12 months postoperatively

Color stability is assessed using a shade guide as a reference standard. The crown color is compared with the shade guide at each follow-up visit (3, 6, and 12 months) according to the following criteria:

0 = No color change.

  1. = Slight change from the original color.
  2. = Unacceptable color change.
3 months, 6 months, 12 months postoperatively
Restoration retention and integrity
Lasso di tempo: 3 months, 6 months, 12 months postoperatively

The clinical condition of the crown is evaluated during follow-up visits according to the following criteria:

0 = No visible fracture.

  1. = Minor crown fracture that is repairable.
  2. = Major crown fracture that can still be repaired.
  3. = Crown loss and exclusion from the study sample.
3 months, 6 months, 12 months postoperatively
Marginal Adaptation
Lasso di tempo: 3 months, 6 months, 12 months postoperatively

Marginal adaptation discrepancies were evaluated clinically using a sharp explorer and direct visual examination under dental operating light According to the modified United States Public Health Service (USPHS) criteria; (A): An Alpha grade represented a clinically ideal restoration with excellent marginal adaptation, no detectable gap on exploratory examination.

(B): A Bravo grade indicated a clinically acceptable restoration with a slight marginal discrepancy detectable by an explorer, but without dentin exposure.

(C): A Charlie grade was assigned to restorations that were clinically unacceptable due to a definite marginal gap, with exposed dentin.

(D): A Delta grade denotes the worst clinical condition, characterized by gross marginal failure, loss of retention, or other major defects, for which complete replacement of the restoration is required.

3 months, 6 months, 12 months postoperatively
Patient/Parent Satisfaction
Lasso di tempo: 3 months, 6 months, 12 months postoperatively

The child and one parent are asked about their satisfaction with the crowns regarding esthetics and function, and the responses are recorded in the patient form. Evaluation is performed as follows:

  1. = Completely satisfied with both esthetic and functional outcomes.
  2. = Satisfied with esthetic and functional outcomes with a minor remark.
  3. = Minor criticism without negative clinical effects or esthetic defects.
  4. = Desire for improvement in esthetic and functional aspects.
  5. = Completely dissatisfied.
3 months, 6 months, 12 months postoperatively

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Collaboratori

Investigatori

  • Investigatore principale: Bushra Munzer Shamma, MSc, DDS., Damascus University
  • Cattedra di studio: Mohannad Laflouf, PhD, MSc, DDS., Damascus University
  • Direttore dello studio: Saleh Al Kurdi, PhD, MSc, DDS., Arab International University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

2 aprile 2024

Completamento primario (Effettivo)

10 dicembre 2025

Completamento dello studio (Stimato)

26 agosto 2026

Date di iscrizione allo studio

Primo inviato

22 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

28 maggio 2026

Primo Inserito (Effettivo)

1 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

1 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

28 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 106/SRC/Sep.23.2024

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi